Annual Accounts Payable
$1.36 M
+$805.70 K+145.38%
December 1, 2023
Summary
- As of February 7, 2025, REVB annual accounts payable is $1.36 million, with the most recent change of +$805.70 thousand (+145.38%) on December 1, 2023.
- During the last 3 years, REVB annual accounts payable has risen by +$494.00 thousand (+57.05%).
- REVB annual accounts payable is now at all-time high.
Performance
REVB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.13 M
+$1.85 M+144.07%
September 1, 2024
Summary
- As of February 7, 2025, REVB quarterly accounts payable is $3.13 million, with the most recent change of +$1.85 million (+144.07%) on September 1, 2024.
- Over the past year, REVB quarterly accounts payable has increased by +$1.85 million (+144.07%).
- REVB quarterly accounts payable is now at all-time high.
Performance
REVB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
REVB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +145.4% | +144.1% |
| 3 y3 years | +57.0% | +144.1% |
| 5 y5 years | - | +144.1% |
REVB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +145.4% | at high | +571.0% |
| 5 y | 5-year | at high | +145.4% | at high | +571.0% |
| alltime | all time | at high | +145.4% | at high | +571.0% |
Revelation Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.13 M(+144.1%) |
| Jun 2024 | - | $1.28 M(-23.8%) |
| Mar 2024 | - | $1.68 M(+23.7%) |
| Dec 2023 | $1.36 M(+145.4%) | $1.36 M(+8.2%) |
| Sep 2023 | - | $1.26 M(+37.6%) |
| Jun 2023 | - | $913.90 K(+29.6%) |
| Mar 2023 | - | $705.10 K(+27.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $554.20 K(-7.1%) | $554.20 K(+18.9%) |
| Sep 2022 | - | $466.10 K(-49.1%) |
| Jun 2022 | - | $916.50 K(-37.3%) |
| Mar 2022 | - | $1.46 M(+145.0%) |
| Dec 2021 | $596.30 K(-31.1%) | $596.30 K(-42.2%) |
| Sep 2021 | - | $1.03 M |
| Dec 2020 | $865.90 K | - |
FAQ
- What is Revelation Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Revelation Biosciences?
- What is Revelation Biosciences annual accounts payable year-on-year change?
- What is Revelation Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Revelation Biosciences?
- What is Revelation Biosciences quarterly accounts payable year-on-year change?
What is Revelation Biosciences annual accounts payable?
The current annual accounts payable of REVB is $1.36 M
What is the all time high annual accounts payable for Revelation Biosciences?
Revelation Biosciences all-time high annual accounts payable is $1.36 M
What is Revelation Biosciences annual accounts payable year-on-year change?
Over the past year, REVB annual accounts payable has changed by +$805.70 K (+145.38%)
What is Revelation Biosciences quarterly accounts payable?
The current quarterly accounts payable of REVB is $3.13 M
What is the all time high quarterly accounts payable for Revelation Biosciences?
Revelation Biosciences all-time high quarterly accounts payable is $3.13 M
What is Revelation Biosciences quarterly accounts payable year-on-year change?
Over the past year, REVB quarterly accounts payable has changed by +$1.85 M (+144.07%)